MENU
NRIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Nurix Therapeutics (NRIX) Earnings Date & Reports

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders... Show more

A.I. Advisor
published Earnings

NRIX is expected to report earnings to rise 59.54% to -82 cents per share on October 09

Nurix Therapeutics NRIX Stock Earnings Reports
Q3'25
Est.
$-0.83
Q2'25
Beat
by $0.19
Q1'25
Beat
by $0.09
Q4'24
Missed
by $0.07
Q3'24
Est.
$-0.67
The last earnings report on July 09 showed earnings per share of -51 cents, beating the estimate of -71 cents. With 450.63K shares outstanding, the current market capitalization sits at 770.61M.
View a ticker or compare two or three
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NRIX showed earnings on July 09, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1700 Owens Street
Phone
+1 415 660-5320
Employees
284
Web
http://www.nurixtx.com